Since we did not observe any overt toxicity with rhododendrin treatment, RNF146 induction and PARP1 inhibition by rhododendrin could serve as a safe therapeutic strategy to halt PARP1-dependent dopaminergic neuron demise in PD. The gene discussed is RNF146; the disease is Parkinson disease.